QQQ   311.16 (-0.18%)
AAPL   156.73 (+3.92%)
MSFT   262.51 (-0.79%)
META   190.31 (+0.82%)
GOOGL   106.69 (-0.97%)
AMZN   106.96 (-5.27%)
TSLA   197.09 (+4.68%)
NVDA   215.78 (-0.60%)
NIO   11.69 (-2.26%)
BABA   107.23 (-2.29%)
AMD   88.02 (-0.33%)
T   19.89 (-1.92%)
MU   63.53 (+0.57%)
F   13.30 (-7.12%)
CGC   3.07 (-2.23%)
GE   83.05 (-1.06%)
DIS   112.75 (-0.41%)
AMC   6.66 (+9.54%)
PFE   44.01 (-0.74%)
PYPL   86.83 (-0.15%)
NFLX   369.27 (+0.65%)
QQQ   311.16 (-0.18%)
AAPL   156.73 (+3.92%)
MSFT   262.51 (-0.79%)
META   190.31 (+0.82%)
GOOGL   106.69 (-0.97%)
AMZN   106.96 (-5.27%)
TSLA   197.09 (+4.68%)
NVDA   215.78 (-0.60%)
NIO   11.69 (-2.26%)
BABA   107.23 (-2.29%)
AMD   88.02 (-0.33%)
T   19.89 (-1.92%)
MU   63.53 (+0.57%)
F   13.30 (-7.12%)
CGC   3.07 (-2.23%)
GE   83.05 (-1.06%)
DIS   112.75 (-0.41%)
AMC   6.66 (+9.54%)
PFE   44.01 (-0.74%)
PYPL   86.83 (-0.15%)
NFLX   369.27 (+0.65%)
QQQ   311.16 (-0.18%)
AAPL   156.73 (+3.92%)
MSFT   262.51 (-0.79%)
META   190.31 (+0.82%)
GOOGL   106.69 (-0.97%)
AMZN   106.96 (-5.27%)
TSLA   197.09 (+4.68%)
NVDA   215.78 (-0.60%)
NIO   11.69 (-2.26%)
BABA   107.23 (-2.29%)
AMD   88.02 (-0.33%)
T   19.89 (-1.92%)
MU   63.53 (+0.57%)
F   13.30 (-7.12%)
CGC   3.07 (-2.23%)
GE   83.05 (-1.06%)
DIS   112.75 (-0.41%)
AMC   6.66 (+9.54%)
PFE   44.01 (-0.74%)
PYPL   86.83 (-0.15%)
NFLX   369.27 (+0.65%)
QQQ   311.16 (-0.18%)
AAPL   156.73 (+3.92%)
MSFT   262.51 (-0.79%)
META   190.31 (+0.82%)
GOOGL   106.69 (-0.97%)
AMZN   106.96 (-5.27%)
TSLA   197.09 (+4.68%)
NVDA   215.78 (-0.60%)
NIO   11.69 (-2.26%)
BABA   107.23 (-2.29%)
AMD   88.02 (-0.33%)
T   19.89 (-1.92%)
MU   63.53 (+0.57%)
F   13.30 (-7.12%)
CGC   3.07 (-2.23%)
GE   83.05 (-1.06%)
DIS   112.75 (-0.41%)
AMC   6.66 (+9.54%)
PFE   44.01 (-0.74%)
PYPL   86.83 (-0.15%)
NFLX   369.27 (+0.65%)
OTCMKTS:KHRNF

Khiron Life Sciences - KHRNF Stock Forecast, Price & News

$0.11
-0.01 (-8.62%)
(As of 02/2/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.10
$0.11
50-Day Range
$0.04
$0.12
52-Week Range
$0.03
$0.22
Volume
446,630 shs
Average Volume
327,006 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
KHRNF stock logo

About Khiron Life Sciences (OTCMKTS:KHRNF) Stock

Khiron Life Sciences Corp. is a vertically integrated medical and consumer packaged goods (CPG) cannabis company with core operations in Latin America and operational activities in Europe and North America. It provides medical cannabis in Colombia and focuses on the cultivation, production, international export, domestic distribution and sale of THC (tetrahydrocannabinol) medical cannabis products. The firm operates through the following segments: Medical Cannabis Products, Health Services, and Wellbeing Products. The Medical Cannabis Products segment involves in growth, production and sale of branded products and services to patients with medical conditions where cannabis can be an acceptable, proven option. The Health Services segment operates its medium complexity health centers offering a suite of health, medical and surgical services in alignment with insurance company partners. The Wellbeing Products segment focuses on delivering the benefits of CBD and hemp across an array of various branded consumer packaged goods, such as Kuida cosmetics line. The company was founded by Álvaro F. Torres on May 16, 2012 and is headquartered in Vancouver, Canada.

Receive KHRNF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Khiron Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

KHRNF Stock News Headlines

Apple, Amazon, and Walmart are Investing in Solar Energy
The global market for solar energy is expected to be worth an astronomical $1 trillion by the end of 2028, with increasing adoption of solar by commercial, non-profit, and public entities. Even Fortune 500 companies such as Apple, Amazon, and Walmart are investing in solar to help save money over the long term. So it's little wonder solar is also becoming one of the fastest growing sectors in the U.S. stock market.
Elon Musk Claims Solar Will Soon Power the World
The world's wealthiest person -- Elon Musk -- is a visionary investor. And he fully expects solar power to be our #1 energy source within a few decades. Utility-scale solar is already becoming the cheapest option for electricity generation globally. So with the push toward clean, renewable energy, it's no wonder solar is also becoming one of the fastest growing sectors in the U.S. stock market.
Khiron Life Sciences Awarded Best Latin American...
Khiron Appoints Helen Bellwood (ACA) as Interim CFO
See More Headlines
Receive KHRNF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Khiron Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:KHRNF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Álvaro F. Torres
    Chief Executive Officer & Director
  • Manuel Buendia
    Vice President-Operations
  • Helen Bellwood
    Chief Financial Officer
  • Jairo Espinoza
    Vice President-Medical Affairs
  • Matt Murphy
    Vice President-Compliance













KHRNF Stock - Frequently Asked Questions

Should I buy or sell Khiron Life Sciences stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Khiron Life Sciences in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" KHRNF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in KHRNF, but not buy additional shares or sell existing shares.
View KHRNF analyst ratings
or view top-rated stocks.

How have KHRNF shares performed in 2023?

Khiron Life Sciences' stock was trading at $0.0415 at the beginning of the year. Since then, KHRNF stock has increased by 155.4% and is now trading at $0.1060.
View the best growth stocks for 2023 here
.

Are investors shorting Khiron Life Sciences?

Khiron Life Sciences saw a increase in short interest in the month of January. As of January 15th, there was short interest totaling 120,000 shares, an increase of 46.9% from the December 31st total of 81,700 shares. Based on an average trading volume of 807,600 shares, the days-to-cover ratio is presently 0.1 days.
View Khiron Life Sciences' Short Interest
.

What is Khiron Life Sciences' stock symbol?

Khiron Life Sciences trades on the OTCMKTS under the ticker symbol "KHRNF."

How do I buy shares of Khiron Life Sciences?

Shares of KHRNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Khiron Life Sciences' stock price today?

One share of KHRNF stock can currently be purchased for approximately $0.11.

How can I contact Khiron Life Sciences?

Khiron Life Sciences' mailing address is 500 Burrard Street, Vancouver, BC V6C. The official website for the company is www.khiron.ca. The company can be reached via phone at (702) 527-3564.

This page (OTCMKTS:KHRNF) was last updated on 2/3/2023 by MarketBeat.com Staff